Plasma Level of Urate among Sudanese with Type 2 Diabetes in Khartoum state, Sudan.
DOI:
https://doi.org/10.31686/ijier.vol2.iss12.282Keywords:
Type 2 diabetes mellitus, Plasma urate, cardiovascular diseaseAbstract
Background: Type 2 diabetes mellitus is an independent risk factor for cardiovascular disease and the risk for cardiovascular disease is increased three to four fold in type 2 diabetes mellitus as compared to non-diabetic population. Hyperuricaemia has been reported to be a potential risk factor for cardiovascular disease in type 2 diabetes mellitus. The objective of this study was to assess the plasma level of urate in Sudanese patients with type 2 diabetes in comparison with apparently healthy (non-diabetic) volunteers as controls.
Methods: This is a descriptive, cross- sectional and hospital-based study conducted during the period from March to May 2011 in Jabir Abu Elez diabetic center and Nurein medical center, both in Khartoum state, Sudan. The study group included 52 NIDDM cases and 30 healthy controls of either sex matched for age and gender. Fasting venous samples were collected from both cases and controls. Serum levels of uric acid, and lipid profile were assayed using commercial reagent kits from Biosystem Company.
Results: In the current study there was a significant increase in plasma urate in type 2 diabetic patients as compared to the control group. There was a significant increase in lipid profile with exception to high density lipoprotein which was significantly reduced. There was insignificant correlation of plasma urea, and lipid profile with both; body mass index and the duration of diabetes.
Conclusion: Hyperuricemia is significantly associated with type 2 diabetes mellitus and can increase the morbidity and mortality of diabetes if not managed in time. Elevated plasma urate levels are associated with increased risk of cardiovascular mortality in type 2 diabetes.
Downloads
References
Safi AJ, Mahmood R, Khan MA, Alhaj A. Association of serum uric acid with type II diabetes mellitus. JPMI.2004 ; 18(1):59-63
Marks V, Teale JD. Hypoglyceamia in adults. Baillie's Clinical Endocrinology and Metabolism. 1993 ;( 3): 705-729. DOI: https://doi.org/10.1016/S0950-351X(05)80215-0
Kumar P, Clark ML. Diabetes mellitus and other disorders of metabolism. Clinical Mdicine. 3rd ed. WB Saunders: London; 2002.
Preis SR , Haong SJ ,Coady S, Pencina MJ, D,Agostio RB, Savage PJ, etal. :Trends in all-cause and cardio vascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart study. Circulation., 2009, 119: 1728-35. DOI: https://doi.org/10.1161/CIRCULATIONAHA.108.829176
Becker BF. Towards the physiological function of uric acid. Free Radic Biol Med.1993;14:615-631. DOI: https://doi.org/10.1016/0891-5849(93)90143-I
Strazzullo P, Puig JG. Uric acid and oxidative stress: relative impact on cardiovascular risk. Nutr Metab Cardiovasc Dis.2007;17:409-414. DOI: https://doi.org/10.1016/j.numecd.2007.02.011
Gersch MS, Johnson RJ. Uric acid and the immune response. Nephrol Dial Transplant.2006;21:3046-3047. DOI: https://doi.org/10.1093/ndt/gfl226
Sanchez-Lozada LG, Nakagawa T, Kang DH, Feig DI, Franco M, Johnson RJ. Hormonal and cytokine effects of uric acid. Curr Opin Nephrol Hypertens.2006; 15:30-33. DOI: https://doi.org/10.1097/01.mnh.0000199010.33929.7f
Clausen JO, Borch JK, Ibsen H, Pedersen O. Analysis of the relationship between fasting uric acid and the insulin sensitivity index. Eur J Endocrinol. 1998; 138 (1) : 63-69. DOI: https://doi.org/10.1530/eje.0.1380063
Moriwaki Y, Yamamoto T, Takahashi S, Suda M, and Higashino K. Effect of Glucose infusion on the renal transport of purine bases and oxypurinol. Nephron. 1995; 69 (4): 424-427. DOI: https://doi.org/10.1159/000188513
Alderman M. uric acid in Hypertension and Cardiovascular Disease. Can J Cardiology. 1999; 15:20-25.
Milionis HJ, Elisaf MS. Management of Hypertension and Dyslipidaemia in Patient Presenting with Hyperuricemia.Curr Med Res Opin., 2000; 16 (3):164-170. DOI: https://doi.org/10.1185/030079900750119252
Hayden MR, Tyagi SC: Uric acid - A new look at an old risk marker for cardiovascular disease, metabolic syndrome and Type II D.M: The urate redox shuttle. Nutr. Metab., 2004, 1: 10.14. Aronson D, Rayfield EJ: How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovasc Diabetol., 2002, 1(1):
Zhang X, Shu XO, Gao YT, Yang G, Mathew CE, Li Q, et.al: Anthropo-metric predictors of coronary heart disease in Chinese women. Int J Obes Relat Metab Disord., 2004, 28: 734-40. DOI: https://doi.org/10.1038/sj.ijo.0802634
Quinone GA, Natali A, Baldi S, and Sanna G. Effect of Insulin on Uric Acid excretion in humans.Am J Physiol,1995; 268(1): 1-5. DOI: https://doi.org/10.1152/ajpendo.1995.268.1.E1
Iwaski N, Ogata M, Tomonaga O, and Kasahara T. Liver and Kidney function in Japanese patients with Maturity- onset Diabetes of the young. Diabetes Care,1998;21(12):2144-2148. DOI: https://doi.org/10.2337/diacare.21.12.2144
Muscelli E, Natali A, Bianchi S, and Ferrannini E. Effect of insulin on Renal Sodium and Uric Acid handling in Essential Hypertention.AM J Hypertens 1996;9(8): 746-752. DOI: https://doi.org/10.1016/0895-7061(96)00098-2
Ishihara M, Shinoda T, Yamada T. Hypercalciuria and Hyperuricemia in Type 2 Diabetic patients. Diabet Med 1989; 5(5): 406-411. DOI: https://doi.org/10.1111/j.1464-5491.1989.tb01194.x
Kodama S, Saito K, Yachi Y, Totsuka K. Association between Serum Uric Acid and Development of Type 2 Diabetes. Diabetes Care 2009; 32. DOI: https://doi.org/10.2337/dc09-0288
Gonen B, Baenziger J, Schonfeld G, Jacobron ., D, Farrar P: Non enzymatic glycosylation of low density lipoprotein in vitro. Effect on cell -interactive properties. Diabetes., 1981, 30(10): 875-888. 526–530. DOI: https://doi.org/10.2337/diabetes.30.10.875
Bowie A, Owens D, Collins P, Johnson A, Tomkins GH: Glycosylated low density lipoprotein is more sensitive to oxidation: implications for the diabetic patient. Atherosclerosis., 1993, 102: 63-67. DOI: https://doi.org/10.1016/0021-9150(93)90084-8
Waring WS, Webb DJ, Maxwell SRJ: Uric acid as a risk factor for cardiovascular disease. Q J Med., 2000, 93: 707-711. DOI: https://doi.org/10.1093/qjmed/93.11.707
Leyva F, Anker SD, Godsland IF, Teixeira M, Hellewell PG, Kox WJ, etal: Uric acid in chronic heart failure : a marker of chronic inflammation . Eur Heart J, 1998, 19: 1814-22. DOI: https://doi.org/10.1053/euhj.1998.1188
Fukui M, Tanaka E, Shiraishi I, Harusato H, Haroda H, Arso M, Kanado G, Hasegoda T, et.al: Serum uric acid is associated with microalbuminuria and subclinical atherosclerosis in men with type 2 diabetes mellitus. Metabolism., 2008, 57: 625-629 DOI: https://doi.org/10.1016/j.metabol.2007.12.005
Talat N, Amir Khan, Gulsena M, Belal B. Dyslipidemias in type 2 diabetes mellitus Patients in a Teaching Hospital of Lahore, Pakistan.Pak J M; 283
Downloads
Published
Issue
Section
License
Copyright (c) 2014 Salma Hussein Elhassan, Bader Eldien Hassan Elabid, Sara osman yousif
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyrights for articles published in IJIER journals are retained by the authors, with first publication rights granted to the journal. The journal/publisher is not responsible for subsequent uses of the work. It is the author's responsibility to bring an infringement action if so desired by the author for more visit Copyright & License.
How to Cite
